{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18050731", "DateCompleted": {"Year": "2009", "Month": "07", "Day": "27"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "01"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "0513-4870", "JournalIssue": {"Volume": "42", "Issue": "9", "PubDate": {"Year": "2007", "Month": "Sep"}}, "Title": "Yao xue xue bao = Acta pharmaceutica Sinica", "ISOAbbreviation": "Yao Xue Xue Bao"}, "ArticleTitle": "[Advances in the study of ginsenoside compound K].", "Pagination": {"StartPage": "917", "EndPage": "923", "MedlinePgn": "917-23"}, "Abstract": {"AbstractText": ["Ginsenoside compound K is the main metabolite of protopanaxadiol type ginseng saponins in intestine after oral administration and also is the major form of protopanaxadiol saponins absorbed to the body. Recently, ginsenoside compound K has received increasing attention, because in vivo or in vitro various biological actions of anticancer, hepatoprotective and anti-inflammatory etc, have shown to be mediated by this metabolite. In this paper, the studies of preparation, bioactivities, absorption, distribution and pharmacokinetics of compound K were reviewed in detail."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Fudan University, Shanghai 200032, China."}], "Identifier": [], "LastName": "Zhou", "ForeName": "Wei", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "Pei", "Initials": "P"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Yao Xue Xue Bao", "NlmUniqueID": "21710340R", "ISSNLinking": "0513-4870"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Ginsenosides"}, {"RegistryNumber": "0", "NameOfSubstance": "Protective Agents"}, {"RegistryNumber": "A9RLM212CY", "NameOfSubstance": "ginsenoside M1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["biosynthesis", "pharmacokinetics", "pharmacology"], "DescriptorName": "Ginsenosides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Liver"}, {"QualifierName": ["metabolism"], "DescriptorName": "Panax"}, {"QualifierName": ["metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protective Agents"}, {"QualifierName": [], "DescriptorName": "Tissue Distribution"}], "NumberOfReferences": "38"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "12", "Day": "7", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "7", "Day": "28", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "12", "Day": "7", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18050731"]}}], "PubmedBookArticle": []}